NextCure, Inc. (NXTC)

Last Closing Price: 12.34 (2025-12-05)

Return on Equity (Quarterly)

Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity

NextCure, Inc. (NXTC) had Return on Equity of -36.47% for the most recently reported fiscal quarter, ending 2025-09-30.

Figures for fiscal quarter ending 2025-09-30
Income Statement Financials
--
$-8.62M
--
--
$8.95M
$-8.95M
$0.32M
$-8.62M
$-8.62M
$-8.62M
$-8.62M
$-8.62M
$-8.62M
$-8.95M
$-8.46M
2.68M
2.68M
$-3.22
$-3.22
Balance Sheet Financials
$32.64M
$3.64M
$6.97M
$39.61M
$10.99M
--
$4.97M
$15.97M
$23.65M
$23.65M
$23.65M
2.68M
Cash Flow Statement Financials
$-41.98M
$19.55M
$2.02M
$27.73M
$7.32M
$-20.40M
$2.55M
--
--
Fundamental Metrics & Ratios
2.97
--
--
--
--
--
--
--
--
--
--
$-41.98M
--
--
--
--
--
--
--
Return on Equity
-36.47%
-36.47%
-21.77%
-36.47%
$8.84
$-15.69
$-15.69